Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
CytomX Therapeutics, Inc. (CTMX)
Sector: Healthcare; Industry: Biotechnology

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. Its product candidates in clinical stage include CX-072, a Probody therapeutic targeting programmed cell death ligand 1 immuno-oncology target; CX-2009, a Probody drug conjugate (PDC) against CD166 novel drug target; BMS-986249, a CTLA-4 Probody therapeutic drug; CX-2029, a PDC targeting CD71; and CX-188, a Probody therapeutic targeting PD-1 anti-cancer target.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-31 McCarthy Sean A. President and CEO Sell 100,000 $7.49 $749,470 Yes
2020-05-12 McCarthy Sean A. President and CEO Sell 36,000 $15.00 $540,000 Yes
2019-03-04 ROWLAND LLOYD A General Counsel Buy 9,000 $10.33 $92,970 No
2018-12-12 RAY DEBANJAN Chief Financial Officer Sell 3,000 $15.00 $45,000 Yes
2018-11-01 RAY DEBANJAN Chief Financial Officer Sell 3,000 $15.00 $45,000 Yes
2018-11-02 McCarthy Sean A. President and CEO Sell 6,526 $15.00 $97,899 Yes
2018-10-01 RAY DEBANJAN Chief Financial Officer Sell 3,000 $18.46 $55,380 Yes
2018-09-04 RAY DEBANJAN Chief Financial Officer Sell 3,000 $22.39 $67,170 Yes
2018-09-04 McCarthy Sean A. President and CEO Sell 13,052 $21.86 $285,343 Yes
2018-08-01 RAY DEBANJAN Chief Financial Officer Sell 3,000 $26.05 $78,150 Yes
2018-07-05 McCarthy Sean A. President and CEO Sell 4,497 $25.06 $112,689 Yes
2018-07-03 McCarthy Sean A. President and CEO Sell 2,028 $25.09 $50,880 Yes
2018-07-02 RAY DEBANJAN Chief Financial Officer Sell 3,000 $22.56 $67,680 Yes
2018-07-02 McCarthy Sean A. President and CEO Sell 13,052 $23.42 $305,708 Yes
2018-06-01 RAY DEBANJAN Chief Financial Officer Sell 3,000 $25.93 $77,793 Yes
2018-05-01 RAY DEBANJAN Chief Financial Officer Sell 3,000 $26.52 $79,562 Yes
2018-05-01 McCarthy Sean A. President and CEO Sell 19,578 $26.55 $519,743 Yes
2018-04-02 RAY DEBANJAN Chief Financial Officer Sell 3,000 $28.12 $84,360 Yes
2018-03-26 GLUCK FREDERICK W Director Sell 5,000 $31.93 $159,642 No
2018-03-02 GLUCK FREDERICK W Director Sell 16,181 $30.00 $485,466 No
2018-03-02 HUMPHREY RACHEL Chief Medical Officer Sell 16,160 $30.00 $484,800 Yes
2018-03-02 RAY DEBANJAN Chief Financial Officer Sell 33,000 $29.99 $989,694 Yes
2018-03-01 McCarthy Sean A. President and CEO Sell 19,578 $29.43 $576,141 Yes
2018-02-28 HUMPHREY RACHEL Chief Medical Officer Sell 23,840 $30.00 $715,200 Yes
2018-02-28 GLUCK FREDERICK W Director Sell 3,819 $30.00 $114,570 No
2018-02-01 RAY DEBANJAN Chief Financial Officer Sell 2,548 $26.69 $68,010 No
2018-01-05 McCarthy Sean A. President and CEO Sell 6,526 $25.01 $163,215 Yes
2018-01-05 GLUCK FREDERICK W Director Sell 10,000 $25.01 $250,078 No
2018-01-02 McCarthy Sean A. President and CEO Sell 13,052 $21.04 $274,614 Yes
2018-01-02 RAY DEBANJAN Chief Financial Officer Sell 2,500 $21.11 $52,775 No

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.